🩸

Hematology

18 drugs in pipeline from 10 companies

Drugs in Pipeline

Companies

Upcoming Catalysts

Phase 3 Trials

Upcoming Catalysts

Sep '26

BAYRYPhase 2$42.5B

✓Positive

BAY2599023 (DTX201) Phase 2 Est. Readout

BAY2599023 (DTX201)• Hemophilia A11

Sep 2026~Confirmed

CT.gov

View all catalysts

Pipeline by Phase

Phase 3

Active Companies

HSCSW

HeartSciences Inc.

6 drugs

TKPHF

TAKEDA PHARMACEUTICAL CO LTD

OTSUKA

NOVO NORDISK A S

HeartSciences Inc.

Sanofi

American Oncology Network, Inc.

GlycoMimetics, Inc.

Chugai Pharmaceutical Co., Ltd.

1 drugs

ILPLF

Island Pharmaceuticals Ltd

1 drugs

Related Conditions

bloodhematologyanemiahemophiliathrombocytopeniacoagulationclottingplatelettransfusionsickle cell